Regelife Request access

Applications

Anywhere cells are grown outside the body.

The matrix is not only a cell therapy problem. It is a cell culture problem, and it shows up in routine work long before it shows up in a clinic.

Routine culture

2D and 3D culture

Replace an undefined coating with a material whose composition you know and can reorder unchanged.

Models

Organoids and disease models

Control the mechanical and adhesive environment that drives organoid formation, instead of inheriting it from a tumour extract.

Stem cells

Differentiation

Stiffness and ligand presentation steer lineage choice. Design them rather than discover them.

Discovery

Drug screening and toxicology

A defined matrix removes one of the larger sources of plate to plate variability in phenotypic assays.

Immunology

Immune cell expansion

Tune the material context that supports expansion and phenotype retention.

Engineering

Tissue engineering

Scaffolds designed against a target mechanical and degradation profile rather than selected from stock.

Translation

Regenerative cell therapy

Where the material stops being a convenience and starts deciding whether the therapy works at all.

Read more

Some workflows tolerate a bad matrix. Others do not.

In routine culture an imperfect material costs you some variability. In transplantation it costs you the experiment, and eventually the therapy. The further a workflow sits toward the right of this ordering, the more the material decides the outcome.

Sensitivity to the material environment

Schematic ordering of how sensitive each workflow is to the material environment. Illustrative only.